Aarey Drugs & Pharmaceuticals Ltd Stock Analysis

BSE: 524412 | NSE: AAREYDRUGS | Trading | Small Cap

BSE Share Price 23-Sep-2022 18:01
39.60 -1.10 (-2.70%)

DeciZen - Make an Informed Decision on Aarey Drugs & Pharma

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity

1. Quality

2. Valuation


3. Price Trend

Aarey Drugs & Pharma Price Chart

P/E Ratio (SA) :
Market Cap :
100.5 Cr.
52-wk low :
52-wk high :
Bole Toh?

1. Is Aarey Drugs & Pharmaceuticals Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Aarey Drugs & Pharmaceuticals Ltd is a below average quality company.

2. Is Aarey Drugs & Pharmaceuticals Ltd undervalued or overvalued?

The key valuation ratios of Aarey Drugs & Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Aarey Drugs & Pharmaceuticals Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Aarey Drugs & Pharmaceuticals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Aarey Drugs & Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Aarey Drugs & Pharmaceuticals Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

ROCE % 2.5%3.2%4.3%4.8%5.1%15.3%10.2%8.7%6.6%7.2%-
Value Creation Index -0.8-0.8-0.7-0.7-0.60.1-0.3-0.4-0.5-0.5-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 130172200213246396349355300348513
YoY Gr. Rt. %-32.1%15.9%6.9%15.3%60.9%-12%1.7%-15.4%16.1%-
YoY Gr. Rt. %-160%53.9%5%20.6%297.4%-15.6%9.4%-11.1%12.1%-
BVPS (₹) 19.419.920.52121.826.633.33638.541.345.1
Adj Net Profit 0.30.711.11.35.566.55.86.55
Cash Flow from Ops. -93.4-
Debt/CF from Ops. -0.51.4-


CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 11.5%7.2%-0%16.1%
Adj EPS 38.3%29.6%2.9%12.1%
BVPS 8.713.67.47.3
Share Price -2.1% -16.3% 34% 8.9%

Key Financial Parameters

Performance Ratio Colour Code Guide

Return on Equity % 0.92333.512.
Op. Profit Mgn %
Net Profit Mgn %
Debt to Equity
Working Cap Days 1641901821791661121481471912090
Cash Conv. Cycle 238672736246374540

Recent Performance Summary

Sales growth is good in last 4 quarters at 51.38%

Return on Equity has declined versus last 3 years average to 4.40%

Sales growth has been subdued in last 3 years -0.02%

Net Profit has been subdued in last 3 years 2.92%

Latest Financials - Aarey Drugs & Pharmaceuticals Ltd.

Standalone Consolidated
TTM EPS (₹) 1.9 -
TTM Sales (₹ Cr.) 513 -
BVPS (₹.) 45.1 -
Reserves (₹ Cr.) 89 -
P/BV 0.88 -
PE 20.78 -
From the Market
52 Week Low / High (₹) 28.50 / 64.40
All Time Low / High (₹) 0.50 / 143.95
Market Cap (₹ Cr.) 101
Equity (₹ Cr.) 25.4
Face Value (₹) 10
Industry PE 128.4

Management X-Ray of Aarey Drugs & Pharma :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Aarey Drugs & Pharma

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)


About Aarey Drugs & Pharmaceuticals Ltd

Aarey Drugs & Pharmaceuticals Ltd. was established in 1990. The company is engaged in the manufacturing of drugs and intermediates such as metronidazole, metronidazole benzoate, methyl, and nitro imidazole. The company is based in Thane, India.

The  company also export its products to various other countries like Germany, Sri Lanka, Pakistan, Nepal and a number of African countries and is looking to establish its trade relations in other parts of the world as well.

Product range of the company includes: API/Intermediate

  • Metronidazol
  • Metronidazole Benzoate
  • 2 Methyl -5-Nitro Imidazole

Drug deliveryPharmaceuticals / Therapeutics

Therapeutic targets of the company's products are:

  • Allergy
  • Dermatology
  • Infectious Diseases

Recent development

Aarey Drugs & Pharmaceuticals  has recently informed that  Atul A Zatakia has resigned from the Company as a Director with effect from March 01, 2009.  

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now